Atreca, Inc. Announces Proposed Underwritten Public Offering of Class A Common Stock
16 July 2020 - 6:01AM
Atreca, Inc. (Nasdaq: BCEL), a biopharmaceutical company utilizing
its differentiated platform to discover and develop novel
antibody-based immunotherapeutics to treat a range of solid tumor
types, today announced that it intends to offer shares of its Class
A Common Stock (the “Shares”) in an underwritten public offering.
In connection with the offering, Atreca expects to grant the
underwriters a 30-day option to purchase additional shares of its
Class A Common Stock. All of the Shares will be offered by
Atreca.
Cowen and Company, LLC, Evercore Group L.L.C.
and Stifel, Nicolaus & Company, Incorporated are acting as
joint book-running managers for the offering. The offering is
subject to market conditions and there can be no assurance as to
whether or when the offering may be completed or the actual size or
terms of the offering.
A shelf registration statement relating to the
offered Shares was filed with the Securities and Exchange
Commission (SEC) on July 2, 2020, and was declared effective
on July 10, 2020. A preliminary prospectus supplement and
accompanying prospectus relating to the offering will be filed with
the SEC and will be available on the SEC’s website,
located at www.sec.gov. Prospective investors should read the
preliminary prospectus supplement, when available, and the
accompanying prospectus and other documents we have filed with
the SEC for more complete information about us and the
offering. Copies of the prospectus supplement and the accompanying
prospectus related to the offering may be obtained, when available,
from Cowen and Company, LLC, c/o Broadridge Financial Services,
1155 Long Island Avenue, Edgewood, NY 11717, Attention: Prospectus
Department, by email at PostSaleManualRequests@broadridge.com or by
telephone at (833) 297-2926; Evercore Group L.L.C., Attention:
Equity Capital Markets, 55 East 52nd Street, 36th Floor, New York,
New York 10055, by email at ecm.prospectus@evercore.com, or by
telephone at (888) 474-0200; or Stifel, Nicolaus & Company,
Incorporated, Attention: Syndicate, One Montgomery Street, Suite
3700, San Francisco, California 94104, or by telephone at
415-364-2720 or by email at syndprospectus@stifel.com.
This press release shall not constitute an offer
to sell or a solicitation of an offer to buy these securities nor
shall there be any sale of these securities in any state or
jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
Cautionary Note on Forward-Looking
Statements
This press release contains forward-looking
statements for purposes of the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Forward-looking
statements include statements regarding Atreca’s expectations
regarding the completion, timing and size of the proposed public
offering. In some cases, you can identify these statements by
forward-looking words such as “expect,” “may,” "will," or the
negative or plural of these words or similar expressions (as well
as other words or expressions referencing future events, conditions
or circumstances). These forward-looking statements are based on
Atreca’s expectations and assumptions as of the date of this press
release. Each of these forward-looking statements involves risks
and uncertainties. Actual results may differ materially from these
forward-looking statements. These risks and uncertainties include,
without limitation, risks and uncertainties related to market
conditions and satisfaction of customary closing conditions related
to the proposed public offering. There can be no assurance that
Atreca will be able to complete the proposed public offering on the
anticipated terms, or at all. Additional information concerning
these and other risks can be found in Atreca’s periodic filings
with the SEC, including under the heading "Risk Factors" contained
therein, as well as the risks identified in the registration
statement and the preliminary prospectus supplement relating to the
offering. Any forward-looking statements that Atreca makes in this
press release speak only as of the date of this press release.
Except as required by law, Atreca assumes no obligation to update
any forward-looking statements, whether as a result of new
information, future events or otherwise, after the date of this
press release.
Atreca Contacts
Atreca, Inc. Herb Cross Chief Financial Officer
info@atreca.com Investors: Alex Gray, 650-779-9251
agray@atreca.com
Media: Sheryl Seapy, 213-262-9390
sseapy@w2ogroup.com
Atreca (NASDAQ:BCEL)
Historical Stock Chart
From Jul 2024 to Aug 2024
Atreca (NASDAQ:BCEL)
Historical Stock Chart
From Aug 2023 to Aug 2024